help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Canny, B. J.
Right arrow Articles by Clarke, I. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Canny, B. J.
Right arrow Articles by Clarke, I. J.

Endocrinology, Vol 125, 2532-2539, Copyright © 1989 by Endocrine Society


ARTICLES

Glucocorticoids regulate ovine hypophysial portal levels of corticotropin-releasing factor and arginine vasopressin in a stress- specific manner

BJ Canny, JW Funder and IJ Clarke
Medical Research Centre, Prince Henry's Hospital, Melbourne, Australia.

Hypophysial portal circulation levels of immunoreactive (ir) CRF, immunoreactive arginine vasopressin (ir-AVP), and systemic ir-ACTH and cortisol were determined in dexamethasone-infused (20 micrograms/h) ewes, both under basal conditions and in response to audiovisual and hypoglycemic stress. Glucocorticoid infusion lowered mean basal levels of ir-CRF (P less than 0.05), ir-ACTH (P less than 0.05), and cortisol (P less than 0.05), but not of ir-AVP. Audiovisual stress led to coordinate release of ir-AVP and ir-CRF, and although the hypothalamic response to this stress was not altered in dexamethasone (DEX)-infused sheep, the pituitary-adrenal response was blocked, suggesting that glucocorticoids act on the pituitary rather than on higher centers to inhibit this response. In contrast, hypoglycemia led to preferential release of ir-AVP over ir-CRF, and DEX infusion delayed and inhibited both hypothalamic and pituitary responses. Ketamine injection also led to preferential release of ir-AVP, but neither the hypothalamic nor pituitary-adrenal responses were affected by DEX infusion. These results suggest that different stressors evoke different patterns of hypothalamic secretagogue release, and that glucocorticoids act in a site-specific fashion to regulate the hypothalamo-pituitary-adrenal responses to stress.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
D. Engler, E. Redei, and I. Kola
The Corticotropin-Release Inhibitory Factor Hypothesis: A Review of the Evidence for the Existence of Inhibitory as Well as Stimulatory Hypophysiotropic Regulation of Adrenocorticotropin Secretion and Biosynthesis
Endocr. Rev., August 1, 1999; 20(4): 460 - 500.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
E. R. de Kloet, E. Vreugdenhil, M. S. Oitzl, and M. Joëls
Brain Corticosteroid Receptor Balance in Health and Disease
Endocr. Rev., June 1, 1998; 19(3): 269 - 301.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society